Best GLP-1 Providers of 2026: Ranked and Reviewed

Finding a GLP-1 provider sounds simple until you actually try. Prices range from $99 to over $1,000 a month depending on the medication type, and dozens of telehealth companies have entered the market since semaglutide became a household name. Sorting out the real differences takes time most people don't have. The single most important distinction is whether a provider offers compounded or brand-name GLP-1s. Compounded medications contain the same active ingredient but are not FDA-approved as finished products, and the price difference is dramatic. This guide ranks the best GLP-1 providers of 2026 based on cost, medication access, support quality, and how well they handle insurance, so you can compare them side by side before committing.

Last verified: October 2026 by RxPickr Editorial Team (a few figures were carried from an earlier cycle because the provider's site blocked our checks: Hers, Oak Longevity, bmiMD, TrimRx, and MEDVi's compounded prices are carried from September 1, and PlushCare's Zepbound and Wegovy figures from May; see the pricing tool for per-entry dates). Every monthly price below was confirmed against the provider's public pricing page or a completed intake quote in our monthly pricing refresh. We re-verify pricing monthly. Our full methodology is at How we rate providers.

Our picks at a glance

These are the category winners from our comparison and provider reviews. Prices are as of October 2026 and may change.

• Cheapest compounded semaglutide and tirzepatide we track: Eden, $99/mo (sema) or $129/mo (tirz), all-inclusive at every dose, month to month. Full review
• Best if you have insurance: PlushCare, the widest brand-name formulary with active prior authorization support; Ro and Found also offer insurance coordination and are worth comparing. Full review
• Cheapest telehealth Wegovy pill (self-pay): Mochi Health, from $228/mo total at the starting dose ($149 medication plus a $79 membership). If you already have a prescription, manufacturer-direct NovoCare (Wegovy pill) and LillyDirect (Foundayo) start at $149/mo. Full review
• Best for coaching and behavioral support: Found (includes a free insurance check) or Noom Med (behavioral science built into the program). Full review
• Cheapest needle-free compounded option: Mochi Health compounded semaglutide pill, from $141/mo at the starting dose ($62 medication plus a $79 membership). For an all-inclusive price with no membership, Henry Meds sublingual semaglutide is $179/mo. Full review

Compounded medications are not FDA-approved as finished products. All GLP-1 medications require a prescription from a licensed provider.

Quick comparison: top GLP-1 providers at a glance

Provider (domain)	Best for	Starting price (verified October 2026)	Medication type
Hims (hims.com)	Brand-name Novo Nordisk catalog (no compounded)	From $149/mo medication + $149/mo membership	Brand Wegovy (pill + pen), Foundayo, Zepbound, Ozempic
Hers (forhers.com)	Brand-name catalog for women	From $149/mo medication + $149/mo membership	Brand Wegovy, Zepbound, Foundayo, Ozempic, Mounjaro
Ro (ro.co)	Insurance coordination	$149/mo membership ($74/mo on 12-mo prepay) + medication (Wegovy pill $149–$299 by dose; pen $199 starter promo, $349–$399 ongoing; Zepbound $299–$449)	Brand Wegovy (pill + pen), Zepbound (vial + KwikPen), Foundayo (brand-name only)
Henry Meds (henrymeds.com)	All-inclusive, no membership	$297/mo (sema injection, mo-to-mo) or $197/mo (12-mo paid in full)	Compounded sema (injection + sublingual + oral), liraglutide, oral tirz tablets
TrimRx (trimrx.com)	Flat-rate compounded	$199/mo (sema) or $349/mo (tirz), flat at every dose; 12-mo prepay from $174/$283	Compounded semaglutide + tirzepatide
Oak Longevity (oaklovesyou.com)	Low compounded rate on a 3-month supply, plus brand-name option	$133/mo (sema) or $199/mo (tirz) on a 3-month supply with checkout code ($200/$250/mo month to month)	Compounded semaglutide + tirzepatide, plus brand Wegovy/Zepbound/Ozempic/Mounjaro at retail prices
Eden (eden.health)	Cheapest compounded sema + tirz, no membership	$99/mo (sema) or $129/mo (tirz), all-inclusive at every dose, month to month; brand-name adds a $99/mo membership	Compounded sema + tirz, brand Wegovy/Zepbound at cash retail
Shed (tryshed.com)	Multi-format compounded (injection, sublingual, lozenge)	From $149/mo (Microdose)	Compounded sema + tirz, brand Wegovy/Zepbound/Foundayo
Enhance.MD (enhance.md)	Microdose compounded tirzepatide	$212/mo (sema) or $280/mo (tirz), 12-mo plan; Microdose Tirz $169/mo	Compounded semaglutide + tirzepatide
PlushCare (plushcare.com)	Insured patients	$19.99/mo + meds	Brand-name full formulary
Found (joinfound.com)	Full program + insurance check	From $169/mo all-in (12-mo plan, compounded medication included); ~$289/mo month-to-month	10+ medications: compounded sema/tirz/liraglutide + brand Wegovy, Zepbound, Foundayo
Noom Med (noom.com/med)	Behavioral coaching	$79 for the first four weeks (limited-time offer), $179/mo ongoing (Microdose)	Compounded semaglutide + tirzepatide
LillyDirect (lilly.com/lillydirect)	Brand tirzepatide + Foundayo, manufacturer-direct	Foundayo from $149/mo; Zepbound $299–$449/mo	FDA-approved Zepbound + Foundayo
NovoCare Pharmacy (novocare.com)	Brand semaglutide, manufacturer-direct	Wegovy pill from $149/mo; Wegovy pen $199/mo intro / $349/mo ongoing; Ozempic $349–$499/mo	FDA-approved Wegovy + Ozempic only (requires existing Rx)
Mochi Health (joinmochi.com)	Per-dose compounded pricing + dietitian access	$139–$178/mo (sema) or $169–$278/mo (tirz), by dose, plus a $79/mo membership ($0 first month on the 1-month plan)	Compounded (injectable + new pill) + full brand catalog
WeightWatchers Clinic (weightwatchers.com/us/clinic)	Group coaching + GLP-1	$74/mo + meds	Brand Wegovy (pill + pen), oral semaglutide

Prices are as of October 2026 per each provider's website (verified post-intake where applicable) and may change.

What's new in 2026: Foundayo (orforglipron)

The FDA approved Eli Lilly's Foundayo, the first oral GLP-1 receptor agonist for chronic weight management, on April 1, 2026 (FDA approval announcement). It's a once-daily pill that doesn't require food or water restrictions. The cheapest verified path is LillyDirect at $149/month for the 0.8mg starter dose, direct from Eli Lilly with no telehealth platform fees, though it's fulfillment-only, so you need an existing prescription from any licensed provider. As of October 2026, six telehealth providers also stock Foundayo with prescribing included: Found, Hers, Hims, Mochi Health, Ro, and Shed, all at $149/month medication for the 0.8mg starter dose. Lilly's own ladder has temporarily dropped the 2.5mg dose to $149/mo and the 5.5mg dose to $199/mo through December 31, 2026 (normally $199 and $299), with 9mg and above at $299/mo; Ro passes through the same promo prices, while other platforms' higher-dose pricing may differ, so confirm at checkout. Total monthly cost depends on each provider's membership structure: Shed at $274/mo total ($149 + $125 Shed Membership), Found at $278/mo total ($149 medication + a $129/mo CORE membership, up from $99 earlier this year), Hers/Hims at $298/mo total ($149 + $149 membership), and Ro at $298/mo total ($149 + $149 membership, $39 the first month). Mochi Health lists Foundayo from $149/mo plus its $79/mo membership ($228/mo total), but that price is homepage-only and unconfirmed at checkout. For patients who want an FDA-approved oral GLP-1 without the regulatory ambiguity of compounded formulations, Foundayo is the most affordable starting price currently available.

---

Hims

Hims entered the GLP-1 market with an official Novo Nordisk partnership and now offers a broad brand-name catalog. The catalog as of October 2026: Wegovy pill ($149/mo medication), Wegovy pen ($199/mo), a new Ozempic Pill (oral semaglutide, $149/mo), Foundayo ($149/mo starter, escalating by dose), Zepbound (vial or KwikPen, $299/mo starter), and Ozempic ($199/mo, off-label for weight loss). All require a $149/month Hims Weight Loss Membership ($39 first month). Hims discontinued oral compounded semaglutide in Q1 2026 after striking a partnership with Novo Nordisk to sell brand-name GLP-1s instead. It suits patients who want brand-name credibility and a low-friction app experience, but Hims does not actively help with insurance prior authorization. See how it stacks up in our Hims vs Ro comparison.

---

Hers

Hers is the women's-focused arm of the Hims & Hers brand and operates under the same Novo Nordisk partnership. The catalog, last confirmed September 1, 2026: Wegovy pill ($149/mo medication), Wegovy pen ($199/mo), Foundayo ($149/mo starter), Zepbound vial or KwikPen ($299/mo starter), Ozempic ($199/mo, off-label for weight loss), the new Ozempic pill ($149/mo), and Mounjaro ($1,899/mo per our May check, essentially retail since Lilly has no self-pay program for Mounjaro; it no longer appears on the weight-loss product grid). All require the $149/month Hers Weight Loss Membership ($39 first month). Hers discontinued its $69/month compounded oral semaglutide pill in March 2026 after the Novo Nordisk partnership, so the platform is no longer a compounded option. forhers.com has blocked our automated pricing checks for several cycles, including October, so these figures are carried forward rather than freshly confirmed; they mirror Hims's catalog, which we did re-verify this month.

---

Ro

Ro's main advantage over most competitors is built-in insurance coordination. The care team actively helps patients navigate prior authorization for brand-name GLP-1s including Wegovy and Zepbound, which most platforms leave entirely to the patient. Catalog as of October 2026: Wegovy (pill or pen), Zepbound (vial or KwikPen, same price), Foundayo, and an added self-pay Ozempic listing. Ro exited compounded semaglutide in 2026 and is now brand-name only, following Hims's earlier move. Ro now publishes a full dose-by-dose table, and it clarifies that the Wegovy pen's advertised $199/month is a limited-time starter promo covering only the 0.25mg and 0.5mg doses; ongoing pricing is $349/month for 1mg to 2.4mg (Wegovy HD at 7.2mg is $399/mo). Wegovy pill is $149 at 1.5mg, $199 at 4mg, and $299 at 9mg and 25mg. Zepbound is $299 at 2.5mg, $399 at 5mg, and $449 at 7.5mg–15mg within the 45-day refill window. Foundayo starts at $149 (2.5mg is also $149 and 5.5mg $199 through December 31, 2026, on Lilly's temporary promo) and steps up to $299 at maintenance doses. Off-label Ozempic is not discounted the way Wegovy is: Ro lists it at roughly $900–$1,100/month list price. Membership is $149/month month-to-month, $39 the first month, with prepay tiers of $99/month (3-month), $89/month (6-month), or $74/month (12-month).

---

Henry Meds

Henry Meds is a true all-inclusive provider: one flat price covers the compounded medication, medical consultations, supplies, and follow-up visits, with no separate membership fee. Pricing varies by commitment length and is published transparently on Henry Meds' programs page (re-confirmed October 2026). Compounded semaglutide injection runs $297/month on month-to-month, $247/month on 6-month paid in full ($1,482 upfront), and $197/month on 12-month paid in full ($2,364 upfront). Compounded liraglutide (a daily-injection alternative) is cheaper at $179/month month-to-month or $119/month on 12-month paid in full. Sublingual semaglutide is $179/month. Henry Meds does not offer compounded tirzepatide as an injection; tirzepatide is available only as oral tablets at $349/month on a 3-month subscription ($297/month if paid in full upfront). The trade-off is minimal support: Henry Meds is primarily an async prescription service with no coaching or dietitian access. Note that compounded medications are not FDA-approved as finished products.

---

TrimRx

TrimRx keeps the model simple: one all-inclusive price covers the compounded medication, medical consultation, supplies, and shipping with no hidden fees. As last confirmed in September 2026 (TrimRx's pricing page blocked our October check, so these figures are carried forward), TrimRx charges a flat $199/month for compounded semaglutide and $349/month for compounded tirzepatide, the same price at every dose. The "$179" headline you may still see is a first-month rate on the month-to-month plan, which renews at $299/month for semaglutide; prepaid plans bring the effective rate down to $174–$209/month for semaglutide and $283–$316/month for tirzepatide depending on commitment length. Verify the exact plan tier at checkout. TrimRx uses a licensed compounding pharmacy. As with all compounded medications, these are not FDA-approved as finished products. TrimRx does not offer brand-name GLP-1s or insurance support.

---

Oak Longevity

Oak Longevity is a compounded GLP-1 platform with no membership fee, non-recurring billing (you choose whether to renew each month), and a credentialed clinical operation: per Oak Longevity's published clinical team page, NVP Medical Group, P.A. handles prescribing, with Michael Regan, MD (board-certified in Emergency Medicine and Obesity Medicine) as Chief Medical Officer, and NVP also staffs physicians for Wisp and Ro, so the clinical infrastructure is shared with established peers. We confirmed pricing live on Oak's checkout menu on September 1, 2026: compounded semaglutide is $133/mo on a 3-month supply billed upfront ($600 total) when Oak's checkout code OAKSAVE200 is applied, or $200/mo without the code (1-month or 3-month), and compounded tirzepatide is $199/mo on a 3-month supply with the code, or $250/mo month to month ($267/mo on the 3-month supply without the code). Compounded oral semaglutide is $245 per 4-week supply. Oak's checkout FAQ says each dose step-up costs roughly $50 to $75 more, which contradicts its "one price, all dosages" banner, so confirm the escalation policy before assuming a flat rate. Oak also sells brand-name GLP-1s on the same checkout menu at retail-level cash prices: Mounjaro $1,100/mo, Ozempic $1,150/mo, Zepbound $1,250/mo, and the Wegovy pen $1,400/mo, all well above the manufacturer self-pay programs for the same drugs. Oak is available in every state except West Virginia and Mississippi. The 503B compounding pharmacy partner is not named publicly.

---

Eden

Eden (now at eden.health after moving from tryeden.com) restructured its compounded GLP-1 pricing after our September check, and it is now the cheapest compounded semaglutide and tirzepatide we track. Compounded semaglutide is $99/month and compounded tirzepatide is $129/month, all-inclusive, with no separate membership fee, no intro rate, and the same price at every dose, month to month with no commitment. That replaces September's structure of $99 or $199 for medication plus a required $99/month membership (about $198 or $298 total). Eden's page says the price is not introductory and advertises what Eden calls a "lifetime price guarantee"; that is Eden's own promise, not something we can verify. Eden also lists brand-name Wegovy ($1,695/mo) and Zepbound ($1,399/mo) at cash retail prices, far above manufacturer-direct paths like NovoCare and LillyDirect, and the brand-name products still require the $99/month Eden Membership ($39 for the first month). Compounded medications are not FDA-approved as finished products.

---

Shed

Shed offers the widest format diversity of any provider reviewed. Shed cut both full-dose compounded injectables in September 2026: compounded semaglutide injection now runs $159/month on the 12-month plan ($179 on 6-month, $199 month-to-month), down from $175/$199/$249, and compounded tirzepatide injection runs $239/month on the 12-month plan ($269 on 6-month, $299 month-to-month), down from $245/$279/$349. A separate Microdose track holds the cheapest entry, unchanged at $149/month for compounded semaglutide and $199/month for compounded tirzepatide. Non-injection prices are also unchanged since being cut earlier this year: sublingual GLP-1 lozenges are $199/month and GLP-1 liquid drops are $229/month, sold as a single product covering both semaglutide and tirzepatide. Brand-name Wegovy, Zepbound, and Foundayo are also available, all requiring an additional $125/month Shed Membership. The "increases at higher doses" and "2-month minimum" language that used to appear on Shed's compounded product pages has been gone since September; confirm at checkout whether either still applies. Compounded products are not FDA-approved as finished products.

---

Enhance.MD

Enhance.MD prices compounded GLP-1s at a flat rate for every dose: $212/month for sema and $280/month for tirz on a 12-month commitment, with the same rate at every dose level. Month-to-month plans run noticeably higher (sema $249/mo, tirz $329/mo). No separate membership fee. The flat $49/$99 first-month promos from earlier in 2026 were retired; the current first-month offer is $100 off 3+ month plans or $50 off month-to-month, so check the offer at signup. The Elite tier combines sema and tirz at $322/month ongoing for patients who switch between molecules. Enhance.MD also offers a Microdose Tirzepatide product at $169/month (1mg/week dose), tied with Found and Mochi Health's starting dose, behind only Eden's $129/month all-inclusive rate among compounded tirzepatide options we track. Compounded medications are not FDA-approved as finished products.

---

PlushCare

PlushCare is the strongest choice for patients with insurance. It accepts Aetna, Humana, Cigna, and others, and board-certified primary care physicians handle prior authorization support. The brand-name formulary is the widest of any platform reviewed here: Wegovy, Zepbound, Saxenda, Rybelsus, Ozempic, and Mounjaro are all available. The membership is $19.99/month plus a $129 initial consultation fee (per PlushCare's website), but medication costs without insurance can reach $900–$1,400/month for brand-name GLP-1s. PlushCare's self-pay Wegovy figure is currently tied to a promo listing an outdated expiration date, so treat that specific number as unconfirmed and get a checkout quote. PlushCare does not offer compounded semaglutide or tirzepatide.

---

Found

Found takes a wider view than most GLP-1 providers. It offers a broad weight-loss medication catalog, runs a free insurance coverage check (Found contacts your insurer directly and reports back), and wraps it all in a full support program including licensed clinicians, health coaches, and a behavior change app. In 2026 Found restructured its compounded pricing into an all-in plan, re-confirmed unchanged in October 2026: the GLP-1 Program includes the compounded medication (semaglutide, tirzepatide, or liraglutide, at one flat rate across all of them and all doses) in a single price, at $169/mo on the 12-month prepaid plan or $289/mo month-to-month (the 6-month tier previously listed around $199/mo no longer appears on Found's pricing page). Brand-name pricing changed in September: Found's pricing page now lists Wegovy pill, Wegovy pen, and Zepbound as "from $650/mo+" with no per-dose breakdown, replacing the specific figures shown earlier in 2026, and the CORE membership for brand-name medication rose to $129/mo month-to-month (down to about $99/mo on the 6-month prepaid tier). Foundayo still shows a starting price, $149/mo, which with the new $129/mo CORE membership works out to $278/mo total, up from $248/mo. Because Found no longer publishes per-dose branded prices, treat its brand-name figures as unconfirmed until you see a checkout quote, and compare Wegovy, Zepbound, or Foundayo against manufacturer-direct pricing (NovoCare, LillyDirect) before assuming Found is competitive on brand. Found also offers an insurance pathway from $39/mo (12-month plan) to $199/mo (month-to-month) plus a roughly $30 per-visit copay for patients with covered brand-name GLP-1s. As with all compounded options, those medications are not FDA-approved as finished products.

---

Noom Med

Noom Med is built on the premise that medication works better alongside behavioral change. The platform combines compounded GLP-1 medications with Noom's established behavioral coaching app, which addresses food psychology and habit formation. Noom cut prices for new accounts effective late July 2026. Three program tiers, per noom.com: the Microdose GLP-1Rx track is now $79 for the first four weeks (a limited-time offer; it was briefly $49 in September), $179/month ongoing (down from $199; compounded semaglutide or tirzepatide at lower doses than the standard track, with exact doses not published); the standard GLP-1Rx track is $129/month first month, $249/month ongoing (down from $279; full-dose compounded sema titration); and the GLP-1Rx Plus Program is $149/month first month (currently discounted from $199), $299/month ongoing (compounded tirzepatide, unchanged). All include the behavioral app, clinical care, and medication in one charge with no separate subscription. Noom also restructured its telehealth fee for brand-name medication (Ozempic, Zepbound, Wegovy): it's now $39 the first month, then $129/month, billed quarterly, with the medication itself still billed separately. Compounded medications are not FDA-approved as finished products.

---

LillyDirect

LillyDirect lets patients buy FDA-approved Zepbound (tirzepatide) and Foundayo (orforglipron) directly from Eli Lilly, bypassing third-party telehealth platforms entirely. LillyDirect remains the cheapest verified path for both Foundayo (the oral GLP-1 pill, $149/mo at 0.8mg starter dose through the Foundayo Self Pay Journey Program) and Zepbound vials ($299/mo for 2.5mg, $399/mo for 5mg, $449/mo for 7.5mg–15mg within the 45-day refill window). Both ladders were re-confirmed on LillyDirect's own pages in October 2026. If you miss the 45-day Zepbound refill window, Lilly lists $499/mo (7.5mg) and $699/mo (10mg–15mg). Foundayo runs $149/mo at 0.8mg, and Lilly has temporarily cut 2.5mg to $149/mo and 5.5mg to $199/mo through December 31, 2026 (normally $199 and $299); 9mg is $299/mo, and 14.5mg/17.2mg are $299/mo with a refill within 45 days (regular prices apply otherwise). The catch is fulfillment-only scope: no telehealth, no prescribing, no coaching, no care team. Patients need an existing prescription from any licensed provider. This is the right choice if your goal is brand-name tirzepatide or oral Foundayo at a predictable cash price with no intermediary.

---

NovoCare Pharmacy

NovoCare Pharmacy is Novo Nordisk's manufacturer-direct fulfillment program, the equivalent of LillyDirect for Wegovy and Ozempic. Patients with an existing prescription can buy at Novo's published self-pay rates without going through a telehealth platform's membership or visit fees. Pricing as of October 2026: the Wegovy pill's promotional $149/mo now applies only to the 1.5mg starting dose (the earlier promo covering 4mg ended August 31); 4mg is $199/mo and 9mg/25mg are $299/mo. Wegovy injectable pen is $199/mo for the first 2 fills at the 0.25mg/0.5mg starter doses (this intro window was extended through December 31, 2026), then $349/mo for 0.25mg–2.4mg (Wegovy HD at 7.2mg is $399/mo). Ozempic (off-label for weight loss) runs the same intro-then-ongoing pattern: $199/mo for the first 2 fills at the starter doses, then $349/mo, with the 2mg dose at $499/mo. NovoCare also added a new Ozempic Pill (oral semaglutide) at $149/$199/$299 by dose, mirroring the Wegovy pill ladder. The catch is that NovoCare is fulfillment-only, it does not provide telehealth visits, prescribing, or care team support. Patients need to obtain a prescription from any licensed provider first, and there's no coaching, dose-management help, or follow-up clinical care included. For users who already have a stable Rx and just want the cheapest brand-name path, NovoCare is the floor on Wegovy pill pricing in our entire database, at least at the starting dose.

---

How we ranked these providers

The providers above were evaluated on four criteria:

Cost and value. We looked at the true all-in monthly cost, including membership fees that are billed separately from medication. A provider charging $99 for medication plus $79 for a mandatory membership is a $178/month program, and we present it that way.

Medication access. Does the provider offer both compounded and brand-name options? Is tirzepatide available, not just semaglutide? Are delivery formats (oral vs. injectable) clearly disclosed? Providers with broader formularies scored higher.

Support and care quality. This includes asynchronous messaging, synchronous visits, registered dietitian access, behavioral coaching, and care team responsiveness. Patients who want medication only and patients who want full programs have different needs, and we tried to match each provider to the right audience.

Insurance handling. Some platforms actively assist with prior authorization, contact insurers directly, and support insured patients through the approval process. Others are self-pay only. This distinction matters a great deal for patients who have coverage they want to use.

Pricing was verified against each provider's website (and post-intake flows where applicable) in October 2026 and may change. A handful of providers block automated pricing checks and are carried from an earlier verification: Hers, Oak Longevity, bmiMD, TrimRx, and MEDVi's compounded prices from September 1, and PlushCare's Zepbound and Wegovy figures from May; those are flagged in their sections above or in the pricing tool. The rankings reflect our editorial judgment, and no provider paid for placement.

---

Which provider is right for you?

If cost is your top priority and you're paying out of pocket, Eden is now the lowest verified price, $99/mo for compounded semaglutide, all-inclusive with no membership fee, the same at every dose, month to month. Mochi Health is next at the starting dose, $139/mo ($60 medication plus its $79 membership), though its per-dose pricing climbs to $178/mo by the top dose. Among other flat-rate options, Shed cut its full-dose compounded semaglutide to $159/mo on the 12-month plan ($199/mo month-to-month), Shed Microdose is $149/mo all-inclusive, and Found is $169/mo all-in on the 12-month plan with the compounded medication included. Oak Longevity is confirmed at $133/mo on a 3-month supply with its checkout code ($200/mo month to month; its FAQ notes dose steps may add $50 to $75). TrimRx is $199/mo flat at every dose. All use compounded semaglutide, which is not FDA-approved as a finished product but contains the same active ingredient as brand-name options. For compounded tirzepatide, Eden is cheapest at $129/mo all-inclusive, then Found, Mochi Health (at its 2.2mg starting dose), and Enhance.MD's Microdose Tirzepatide tie at $169/mo, and Shed's full-dose compounded tirzepatide was just cut to $239/mo on the 12-month plan. Henry Meds does not offer compounded tirzepatide as an injection, only as oral tablets at $349/mo.

If you have insurance and want to use it, PlushCare is the most insurance-capable platform reviewed here, with the widest brand-name formulary and active prior auth support. Ro and Found also provide insurance coordination and are worth comparing. Prior authorization for brand-name GLP-1s can take 2–4 weeks, so start the process early.

If you want brand-name medication without insurance involvement, Mochi Health now has the cheapest telehealth Wegovy pill total, $228/mo ($149 medication plus its $79 membership). Hims (Wegovy pill from $149/mo or pen from $199/mo, plus the $149/mo membership), Hers (same brand-name catalog plus Foundayo and Zepbound), and LillyDirect (Zepbound direct from Eli Lilly) are the other clearest self-pay brand-name options. LillyDirect's fixed-price program is particularly predictable, with $299/mo for 2.5mg vials and $449/mo for 7.5mg–15mg vials within the refill window. Shed also offers brand-name options at a competitive starter rate ($274/mo total for the Wegovy pill) if you want a single platform for both compounded and brand-name access. Found's brand-name catalog now starts around $650/mo, so it's no longer a starter-price pick outside its compounded plan.

If you want coaching or behavioral support alongside medication, Found and Noom Med both wrap clinical prescribing inside a structured program. Found offers the free insurance check as a differentiator. Noom Med is the better fit if you want behavioral science integrated into the program rather than just check-ins. WeightWatchers Clinic is worth considering if you value group coaching and the WW community structure alongside your prescription.

If injections are a dealbreaker, the cheapest brand-name oral path is the Wegovy pill at Mochi Health, $149/mo medication + $79/mo membership = $228/mo total, followed by Shed at $149/mo medication + $125/mo Shed Membership = $274/mo total. Hims and Hers offer the same Wegovy pill at $149/mo medication + $149/mo membership = $298/mo total. Foundayo (orforglipron) at Shed ($274/mo total), Found ($278/mo), Hers, or Hims ($298/mo) is the cheapest FDA-approved oral GLP-1 alternative at the starter dose. For compounded options, Mochi Health's once-weekly compounded semaglutide pill is the cheapest non-injection path we track, from $141/mo at the starting dose ($62 medication plus its $79 membership); Henry Meds sublingual semaglutide is $179/mo all-inclusive with no membership. Shed offers sublingual lozenges ($199/mo) and liquid drops ($229/mo). Clinical evidence for non-injection compounded formulations is more limited than for injections.

The right answer depends on your specific situation. A licensed healthcare provider can help you weigh medication options, review your health history, and determine whether GLP-1 therapy is appropriate for you.